A new joint venture between Colorado-based Colibri Heart Valve LLCand the HangZhou, China, device firm Venus MedTech has been formed to bring two transcatheter aortic heart valve replacement (TAVR) devices based on Colibri's "dry" tissue technology to market in China and other emerging markets, including India.
Colibri's novel “dry” porcine pericardium processing technology allows for the manufacture and packaging of a transfemoral aortic valve system that...